CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $5.61 billion. The enterprise value is $4.10 billion.
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 90.95 million shares outstanding. The number of shares has increased by 5.50% in one year.
| Current Share Class | 90.95M |
| Shares Outstanding | 90.95M |
| Shares Change (YoY) | +5.50% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 78.74% |
| Float | 90.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 139.28 |
| Forward PS | 86.96 |
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 107.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.61, with a Debt / Equity ratio of 0.13.
| Current Ratio | 16.61 |
| Quick Ratio | 16.49 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.34% and return on invested capital (ROIC) is -13.78%.
| Return on Equity (ROE) | -25.34% |
| Return on Assets (ROA) | -13.05% |
| Return on Invested Capital (ROIC) | -13.78% |
| Return on Capital Employed (ROCE) | -23.70% |
| Revenue Per Employee | $96,819 |
| Profits Per Employee | -$1.19M |
| Employee Count | 393 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.98 million in taxes.
| Income Tax | 3.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.30% in the last 52 weeks. The beta is 1.81, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | +34.30% |
| 50-Day Moving Average | 57.84 |
| 200-Day Moving Average | 45.88 |
| Relative Strength Index (RSI) | 60.33 |
| Average Volume (20 Days) | 2,331,039 |
Short Selling Information
The latest short interest is 23.81 million, so 26.18% of the outstanding shares have been sold short.
| Short Interest | 23.81M |
| Short Previous Month | 22.07M |
| Short % of Shares Out | 26.18% |
| Short % of Float | 26.31% |
| Short Ratio (days to cover) | 12.64 |
Income Statement
In the last 12 months, CRSP had revenue of $38.05 million and -$467.80 million in losses. Loss per share was -$5.44.
| Revenue | 38.05M |
| Gross Profit | -382.46M |
| Operating Income | -456.21M |
| Pretax Income | -463.82M |
| Net Income | -467.80M |
| EBITDA | -437.25M |
| EBIT | -456.21M |
| Loss Per Share | -$5.44 |
Full Income StatementBalance Sheet
The company has $1.72 billion in cash and $215.45 million in debt, giving a net cash position of $1.51 billion or $16.56 per share.
| Cash & Cash Equivalents | 1.72B |
| Total Debt | 215.45M |
| Net Cash | 1.51B |
| Net Cash Per Share | $16.56 |
| Equity (Book Value) | 1.71B |
| Book Value Per Share | 19.36 |
| Working Capital | 1.63B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$324.77 million and capital expenditures -$796,000, giving a free cash flow of -$325.57 million.
| Operating Cash Flow | -324.77M |
| Capital Expenditures | -796,000 |
| Free Cash Flow | -325.57M |
| FCF Per Share | -$3.58 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,198.98% |
| Pretax Margin | -1,218.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.50% |
| Shareholder Yield | -5.50% |
| Earnings Yield | -8.34% |
| FCF Yield | -5.80% |
Dividend DetailsAnalyst Forecast
The average price target for CRSP is $72.59, which is 17.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $72.59 |
| Price Target Difference | 17.71% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 132.06% |
| EPS Growth Forecast (5Y) | -48.51% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 6.39 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.39 |
| Piotroski F-Score | 2 |
